Publication | Open Access

Low-dose methotrexate is ineffective in primary biliary cirrhosis: Long-term results of a placebo-controlled trial

HepatologyMedicineLiver PhysiologyLow-dose MethotrexatePlacebo-controlled TrialPharmacotherapyBiliary DisorderPrimary Biliary CirrhosisHepatotoxicityLiver DiseasePharmacologyDrug-induced Liver InjuryAutoimmune Liver Disease